Precigen, Inc. (PGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 9, 2022, details the results of Precigen, Inc.'s 2022 Annual Meeting of Shareholders. The company is incorporated in Virginia and its common stock trades on the Nasdaq Global Select Market under the symbol PGEN.
Key Financial Metrics
This filing is a corporate governance report regarding shareholder votes and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Shareholder Votes
Shareholders voted on five proposals at the Annual Meeting. All proposals were approved by the requisite majority of votes cast.
- Proposal 1 (Election of Directors): All 10 director nominees were elected. Notable voting results included Dean Mitchell, who received the highest "Against" vote count (20,329,388), and Helen Sabzevari, who received the lowest "Against" vote count (2,007,507).
- Proposal 2 (Auditor Ratification): Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- Proposal 3 (Executive Compensation): Shareholders approved a non-binding advisory resolution regarding the compensation of named executive officers. This proposal received significant opposition, with 26,635,629 votes cast against.
- Proposal 4 (2013 Omnibus Plan Amendment): Shareholders approved an amendment to increase the number of shares available for awards under the 2013 Omnibus Incentive Plan by 10 million.
- Proposal 5 (2019 Non-Employee Plan Amendment): Shareholders approved an amendment to increase the number of shares available for awards under the 2019 Incentive Plan for Non-Employee Service Providers by 7 million.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a report of the voting outcomes.
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the specific terms of the 10 million and 7 million share increases to assess potential dilution impact.
- Analyze the high "Against" vote count for the executive compensation proposal (Proposal 3) and the specific director (Dean Mitchell) to gauge shareholder sentiment.
- Confirm the effective date of the auditor ratification for the 2022 fiscal year.